- Medrio is a leading provider of clinical trial technology, specializing in electronic data capture (EDC) solutions that combine enterprise-grade rigor with no-code agility for small and scaling clinical teams.
- In January 2025, Medrio launched AI-enabled reporting within its CDMS/EDC platform to enhance data exploration and visualization, addressing the increasing data challenges in clinical trials.
- Medrio's solutions are trusted by industry leaders and have supported thousands of completed clinical trials across 30+ countries, showcasing its extensive experience and reliability in the life sciences sector.
- Ideal buyers include life sciences sponsors and contract research organizations (CROs) seeking efficient, flexible, and scalable clinical trial solutions to reduce costs and accelerate timelines, making Medrio's offerings particularly relevant in today's data-intensive research environment.
Medrio's workforce is structured across 10 departments, with a notable concentration in Information Technology, which employs 23 individuals. Operations follows closely with 19 employees, while Sales and Engineering contribute 12 and 10 staff members, respectively. This distribution indicates a strong emphasis on technology and operational efficiency, supporting the company's software development focus. The presence of diverse functional areas, including Marketing, Human Resources, and Finance, further enhances organizational balance.
The company's workforce is geographically distributed across 24 locations, with the primary concentration in San Francisco, CA, housing 31 employees. Other notable locations include Pleasanton, CA, and Perrysburg, OH, each contributing to the overall headcount. The 'Other' category, which accounts for 44 employees, suggests a significant remote or distributed workforce, reflecting Medrio's flexible operational model. This distribution highlights both geographic diversity and a central hub in California.
